Association Between Migraine and Non-Alcoholic Fatty Liver Disease (NAFLD): A Hospital-Based Observational Study
Journal of Diabetes, Metabolism and Endocrinology · 10.11.2026 · 7 (4) · 153-165
DOI: 10.61336/jdme.0704.22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, Metabolism and Endocrinology, online erschienen am 10.11.2026. Verfasst von Adarsh Kumar Sonkar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Migraine is a complex neurovascular disorder characterized by recurrent disabling headaches, while non-alcoholic fatty liver disease (NAFLD) represents a hepatic manifestation of metabolic dysfunction. Emerging evidence suggests shared metabolic, inflammatory, and oxidative pathways linking these two conditions, yet their interrelationship remains poorly elucidated in the Indian population.
Objectives
To evaluate the association between migraine and NAFLD, to analyze the pattern and severity of headache in NAFLD patients with migraine, and to assess correlations between migraine characteristics and biochemical markers of NAFLD.
Methods
A hospital-based, open-label observational study was conducted in the Departments of General Medicine and Radiodiagnosis, Jawaharlal Nehru Medical College, Aligarh. Ninety-four clinically diagnosed migraine patients were enrolled after informed consent and ethical clearance. Each participant underwent anthropometric evaluation, liver function testing, lipid profiling, and ultrasonographic screening for NAFLD. Statistical analysis was performed using SPSS version 16.0, applying Chi-square and unpaired t-tests, with significance set at p<0.05.
Results
Among 94 patients, 84% were female and 30.9% experienced migraine with aura. The majority were aged below 30 years. Alanine aminotransferase (ALT) levels were significantly higher in patients with aura (38.62±19.41 U/L) compared to those without (31.25±14.06 U/L; p = 0.04). Alkaline phosphatase also showed a significant difference (p = 0.01). No significant variations were observed in anthropometric, blood pressure, or lipid parameters. However, patients with aura had markedly higher attack frequency (9.17±3.04 vs 5.58±2.45 months; p = 0.001), greater attack severity (6.12±0.99 vs 3.87±1.39; p = 0.001), and longer attack duration (30.66±22.23 h vs 12.03±12.24 h; p = 0.001). The presence of hepatic grade (GRD) correlated significantly with aura occurrence (p = 0.0001).
Conclusion
The study demonstrates a significant association between migraine—particularly migraine with aura—and biochemical markers of NAFLD, indicating a possible role of hepatic metabolic dysregulation and oxidative stress in migraine pathophysiology. Early identification of NAFLD in migraine patients could help mitigate long-term vascular and metabolic complications.
Zitieren
APA
Sonkar, A. K., & Chughtai, A. M. (2026). Association Between Migraine and Non-Alcoholic Fatty Liver Disease (NAFLD): A Hospital-Based Observational Study. Journal of Diabetes, Metabolism and Endocrinology, 7(4), 153-165. https://doi.org/10.61336/jdme.0704.22
Vancouver
Sonkar AK, Chughtai AM. Association Between Migraine and Non-Alcoholic Fatty Liver Disease (NAFLD): A Hospital-Based Observational Study. Journal of Diabetes, Metabolism and Endocrinology. 2026;7(4):153-165. doi:10.61336/jdme.0704.22
BibTeX
@article{Sonkar2026,
author = {Sonkar, Adarsh Kumar and Chughtai, Anjum Mirza},
title = {Association Between Migraine and Non-Alcoholic Fatty Liver Disease (NAFLD): A Hospital-Based Observational Study},
journal = {Journal of Diabetes, Metabolism and Endocrinology},
year = {2026},
volume = {7},
number = {4},
pages = {153--165},
doi = {10.61336/jdme.0704.22}
}
EUVIMED